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Abstract  
Objectives: To compare muscle and bone health markers in adult males (aged 20-59 
yrs) with and without muscular dystrophy (MD).  
Methods: Participants included 11 Fascioscapulohumeral (FSH), 11 Becker’s (Be), 9 
limb girdle (LG), 11 Duchenne (DMD), and 14 non-dystrophic controls (CTRL). Physical 
activity was assessed using Bone (BPAQ) and disability specific (PASIPD) 
questionnaires. Bone QUS provided T- and Z scores from the Distal Radius (DR) and 
Mid-shaft tibia (MST).  Tibialis anterior cross sectional area (TAACSA) was measured 
using B-mode ultrasound. Grip strength was measured in all but DMD. 
Results: Physical activity was lower in DMD, FSH and BeMD than CTRL (P<0.05), and 
lower in DMD than other MDs (P<0.01). T and Z scores were lower in DMD and Be 
than CTRL (DR, P<0.05); and lower in DMD than CTRL, LG, and FSH (MST, P<0.01). 
TAACSA and grip strength was 35-59% and 50-58% smaller in MD than CTRL, 
respectively (P<0.01). Within MD, BPAQ correlated with bone QUS measures (r=0.42-
0.38, P<0.01). PASIPD correlated with grip strength (r=0.65, P<0.01) and TAACSA 
(r=0.46, P<0.01).  
Conclusion: Muscle size, strength, and bone health was lower in adult males with MD 
compared to adult males without MD, the extent of this is partially determined by 
physical activity. 
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TAACSA = Tibialis anterior Anatomical cross sectional area 
FSH = Fascioscapulohumeral 
Be = Becker’s 
DMD = Duchenne muscular dystrophy 
LG = Limb Girdle 
MD = Muscle dystrophy 
CTRL = Control 
BPAQ = Bones specific physical activity questionnaire 
PASIPD = Physical Activity Score for Individuals with Physical Disabilities 
DR = Distal radius 
MST = mid-shaft tibia 
QUS = quantitative ultrasound  
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Introduction 
Muscular dystrophy (MD) is a term given to a heterogeneous group of a neuromuscular 
disorders characterised by a genetic predisposition to an absence or reduction in a 
variety of proteins within and around the sarcolemma e.g., the sarcoglycan complex 1. 
Some of these conditions have well established genetic and molecular characteristics; 
for example, Duchenne Muscular Dystrophy (DMD) and Becker’s Muscular Dystrophy 
(Be) are characterised by an absence or reduction in dystrophin, respectively. Limb 
Girdle Dystrophy (LG) is classically characterised by a deficiency or loss of the 
sarcoglycan proteins (β, δ or ϒ 2); however there have now been over 20 types of LG 
MD identified, each with distinct sarcolemmal proteins being affected 3.   Within 
Facioscapulohumeral (FSH) Dystrophy, light has recently been shed on the genetic 
origins of the condition with the aberrant expression of the DUX4 gene in skeletal 
muscle recently identified 4.  
Similar to the distinct locus of impairment within the various proteins of the 
sarcolemma, the functional outcomes of these conditions are distinct in terms of the 
progression of the condition, and the pattern of impairment 1. They are however similar 
in that they are all associated with a loss of physical function 5. Despite the established 
neuromuscular impairments of the muscular dystrophies, the direct comparison of in 
vivo muscle size and function between conditions, and with age matched adult control 
groups is limited. In mice with a form of dystrophy (MDX mice), muscles appear larger 
but weaker 6, and muscle architecture is altered consistent with an increase in muscle 
size 7.  Until recently, descriptive in vivo data on whole muscle size and function 
remained limited to a single study reporting muscle strength and size in DMD 8.  
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However, this involved a convenience sample of twelve individuals aged between 7-18 
yrs old, compared to a control population of five individuals aged between 14-45 yrs 
old. Regardless of these limitations, it represents the only evidence that muscle size is 
initially increased in DMD, a similar pattern to that which is observed in MDX mice 9.  In 
contrast, our recent data from adults with DMD was at odds with the data from children, 
with significant atrophy observed in the Gastrocnemius of adults with the condition 10. 
Data on muscle size from other muscle dystrophies remains unreported from an adult 
population. 
A reduction in physical activity, and an associated decrease in loading and muscle 
mass is known to impact on bone health through reductions in bone mineral density, 
changes to bone architecture 11.  It has previously been established that children with 
DMD (mean age = 10 yrs) have a lower bone density than children without the 
condition 12, and that this is likely to contribute to the greater incidence of long bone 
fractures in adults with DMD and Be MD 13. However, as with descriptive data on 
muscle size and strength (two of the main covariables of muscle mass), there is no 
extant data on appendicular bone health in adult males with muscular dystrophy, and 
no comparison between the ambulatory and non-ambulatory forms of muscular 
dystrophy. It is possible that the lack of available data may be due to two predominate 
factors that of the cost and availability of peripheral quantitative computed tomography 
(pQCT) and dual-energy X-ray absorptiometry (DXA) scanners, alongside joint mobility 
issues that may be experienced when positioning individuals with muscle dystrophy 
during the scan.  In contrast, portable quantitative ultrasound scanners (QUS) provide 
an estimate of bone mineral density based on speed of sound through regions of 
interest in the appendicular skeleton, without radiation, and allowing the analysis of 
individuals with limited mobility to be tested in situ. Although these QUS techniques are 
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not suitable for providing a definitive clinical diagnosis of osteopenia, they show good 
agreement with pQCT measures of bone mineral density and measures of a bone’s 
material properties 14; and provide a valid method for comparing appendicular bone 
health between population groups 15.  
Therefore, the aim of the present study was to describe the bone health in the radius 
and tibia in adult males with four forms of human muscular dystrophy, compared to 
adult males without the dystrophic condition.  
Material and Methods 
Participants 
Fifty-six adult males volunteered for this study. Participants were grouped based on 
their dystrophic condition. The participant characteristics of each muscular dystrophy 
group and the non-dystrophic control group are described in Table 1. Participants 
with muscular dystrophy were recruited from, and tested at, The Neuromuscular 
Centre (Winsford, UK). All dystrophy participants were receiving weekly 
physiotherapy treatment involving passive mobility activities lasting approximately 1 
hour. All control participants self-reported as being sedentary undertaking less than 1 
hour of recreational physical activity; none of the participants were undertaking any 
structured, or regular exercise training regimes.  
All procedures conformed to the standards set by the latest revision of the 
Declaration of Helsinki 16, and were approved by the local Ethics Committee of 
Manchester Metropolitan University, Cheshire. Written informed consent was 
obtained from all participants prior to inclusion in this study. 
Procedures 
7 
 
Participants with muscular dystrophy were tested during a single visit to the 
Neuromuscular Centre. All tests were carried out prior to their regular physiotherapy 
session. Control participants were tested in the Muscle Function Lab (MMU-
Cheshire, UK). During the single testing session, stature and mass were measured 
using a wall mounted stadiometer (Harpenden, Holtain Crymych, UK) and digital 
scales (Seca model 873, Seca, Germany) respectively.  In the Dystrophic groups if 
standing stature could not be measured, arm span was recorded. In order to account 
for the known discrepancy between standing height and arm span measures, a 
correction was applied consistent with regression data from adult Caucasian males, 
the known error of making this correction is 3.5% 17. Participant height is presented 
as this corrected value. Where necessary, digital seated scales were adopted for the 
non-ambulatory participants (6875, Detecto, Webb City, MO, USA). Measures of 
muscle size and bone health were obtained with all participants in a seated position. 
All measurements were taken from the participant’s self-reported dominant side. All 
participants completed a bone specific physical activity questionnaire (BPAQ) 
consistent with Weeks and Beck 18. The BPAQ data was analysed using freeware 
developed by Weeks and Beck, and is presented as the “Total” BPAQ, a 
combination of current and past physical activity known to be significant predictors of 
bone strength and health 18. The individuals with muscular dystrophy also completed 
a disability specific physical activity questionnaire (PASIPD – Physical Activity Score 
for Individuals with Physical Disabilities) to account for reduction in physical activity 
associated with various physical disabilities 19. This encompasses a lower activity 
threshold and has subsequently been validated as a reliable outcome measure for 
physical activity in people with disability 20. Aside from measures of mass and stature 
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(as described above), all participants were tested using the same equipment 
regardless of testing location. 
Corticosteroid Therapy 
As previously demonstrated, long-term steroid therapy (> 30 months) is known to 
adversely affect bone mineral density (BMD) 21. Based on self-report, none of the 
individuals of the DMD group were currently on long-term steroid therapy, with 2 
individuals having discontinued long-term steroid therapy at least two years prior to 
enrolment on the study. No individuals of any other group were using, or had 
previously been prescribed, long-term steroid therapy for a period of more than 1 
year. 
Bone measurements 
Bone ratio data (T and Z scores) were obtained using the Sunlight Omnisense™ 
ultrasound scanner (Sunlight Omnisense 8000p device, Tel Aviv, Israel), at two sites: 
the Distal Radius (DR), and at the Mid Shaft Tibia (MST). 
Distal radius QUS scans were taken at 50% of forearm length, measured from the 
point of the elbow (olecranon) to the tip of the middle finger, with the wrist straight 
and the fingers extended. DR scans were recorded with the participant seated, 
elbow flexed at 90º, with a neutral hand rotation. The forearm was raised from the 
flat, resting surface using a foam support, and scans were recorded over the anterior 
region of the radius. MST scans were conducted at 50% of lower limb length, 
measured as the distance from the base of the heel (calcaneus) to the tip of the 
patella (proximal side), with the participants in a seated position. QUS scans were 
recorded over the medial anterior aspect of the tibia.  
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QUS measurements were taken by tilting the probe repeatedly over the surface of 
the bone, above the region of interest, in a 140º approximate arc, each arc taking 
approximately 5s. QUS uses fixed-point transmission techniques to measure 
amplitude-dependent speed of sound (SOS); QUS data is presented as T-score 
values, which can be calculated as: T-score (subject measurement - peak young 
adult mean)/(SD peak young adult mean). Z-Scores are calculated relative to age-
matched normative data. 
Tibialis Anterior ACSA 
TA muscle size is known to be associated with tibial bone density 11, therefore TA 
anatomical cross sectional area (TAACSA the area of the muscle at right angles to the 
longitudinal axis of the muscle) was measured following bone QUS scans.  TAACSA 
was recorded using B-mode ultrasonography (myLab 25, Esaote, Genoa, Italy), 
using a linear array probe (7.5 MHz, 6 cm width). Scans were recorded at a TA 
length consistent with the previously established maximum ACSA of the TA, 
equivalent to 1/3rd of muscle length from the proximal origin of the muscle 22.  TA 
length was measured as the linear distance from the proximal origin (identified as the 
distal edge of the lateral tibial condyle using ultrasonography) to the distal TA 
myotendinous junction, identified through sagittal plane ultrasonography. TAACSA was 
recorded with the participant seated and their leg extended and supported under the 
ankle. At 1/3rd of TA muscle length echo-absorptive markers were placed in parallel, 
at intervals of 30 mm, from the lateral to the medial edge of the TA muscle. The 
ultrasound probe was held perpendicular to the TA muscle in the axial plane. The 
ultrasound probe was moved steadily over the echo-absorptive markers from the 
lateral to the medial edge of the muscle. Constant, light pressure was placed on the 
muscle during scanning to avoid compression of the muscle. The images were 
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recorded in real time at a rate of 25 frames per second (DartfishPro, Fribourg, 
Switzerland). Digital imaging software was used to reconstruct image captures of the 
TA between the echo-absorptive markers (GNU Image Manipulation Program, 
www.gimp.org), from which the entire TA muscle was reconstructed on a digital 
canvas. Digital analysis software (ImageJ 1.45, National Institutes of Health, USA) 
was used to measure TAACSA. This method of calculating ACSA has previously been 
accepted as reliable and valid when compared to MRI in the Vastus Lateralis, with a 
reported interclass correlation between 0.998 and 0.999 23. It should also be noted 
that in a number of the dystrophy participants digital reconstruction was unnecessary 
as the entire TAACSA was visible in a single ultrasound image. 
Grip strength 
Due to the complexity of the wrist and finger musculature, it was not possible to 
obtain suitable muscle size measurements using ultrasonography. Therefore, based 
on previous associations between grip strength and upper limb bone density 24, 
those individuals who were capable, completed a grip strength protocol.  
An analogue handgrip dynamometer (TKK 5101 Grip-D, Takey, Tokyo, Japan) was 
used to assess grip strength following the bone and TA ultrasound scans. Of those 
participants (i.e. 33 of 56) that could produce a measureable grip force, three 
maximal attempts were made. Participants performed three, 5 second, maximal grip 
efforts in a seated position with the dominant hand, with the hand held in a relaxed 
position by their side.  All three tests were separated by a one-minute duration, and 
the peak reading recorded. Test-retest reliability for this protocol has previously been 
reported as high, with low measurement error 25. 
Statistics 
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IBM SPSS Statistics 21 software was used to analyse the data. All variables showed 
homogeneity of variance (Levene’s test, P>0.05), except for BPAQ and Washburn 
scores. Washburn scores and Age violated the parametric assumption of normal 
distribution (Shapiro-Wilk test, P<0.05), all other variables were normally distributed. 
Differences between the groups was analysed using a one-way between groups 
ANOVA with Bonferroni post hoc. Variables that violated normal distribution were 
compared between groups using the Kruskal Wallis test, with post-hoc Mann-
Whitney U pairwise comparisons, where appropriate.  
Pearson’s correlations were carried out to highlight any relationships between 
specific variables (e.g. Grip strength and T score DR; Grip strength and Z score DR; 
TA area and T score MST; TA area and Z score MST). Following significant 
correlations being observed for BPAQ with all T- and Z-scores, and Age with MST T- 
and Z-scores; one way ANCOVA was conducted to determine whether 1) a 
difference between participant groups T- and Z scores remained whilst controlling for 
BPAQ and 2) Age has a significant influence on any of the group comparisons for 
MST. 
Due to the fact that some values are close to zero, relative differences were not 
calculated for T and Z scores. All data are reported as means (SD). Statistically 
significant differences and/or associations were accepted at α≤0.05 
 
Results 
Participants 
FSH participants were significantly older than CTRL and DMD participants (P<0.01, 
Table 1). When age was included as a covariable, only MST Z-scores were 
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significantly influenced as a covariable (ANCOVA, P<0.05), and this is discussed in 
the bone section below. DMD participants had shorter stature than FSH, Be and 
CTRL participants (Table 1, P<0.01) and had significantly less body mass than LG, 
and FSH participants (Table 1, P<0.05).  
 
Physical activity and disability 
BPAQ was higher in CTRL compared to FSH, DMD and Be MD (Figure 1, P<0.05). 
DMD had lower physical activity levels than all other groups (Figure 1, P<0.05). 
There was no difference between the BPAQ of other muscular dystrophy groups. 
PASIPD was lower in DMD than all other Dystrophy groups (P<0.01, Table 1). FSH, 
LG and Be MD participants showed no difference in PASIPD. 
Muscle size and strength 
TAACSA was 35, 56, 55 and 59% smaller in Be, DMD, FSH and LG compared to 
CTRL (Figure 2, P<0.01). In addition, LG, FSH and DMD had a smaller TAACSA than 
Be (Figure 2, P<0.05). There was no difference in TAACSA between LG, FSH and 
DMD groups.  
Compared to the CTRL participants Grip strength was 50, 58 and 54% lower in FSH, 
LG and Be participants, respectively (Table 1, P<0.01). DMD participants were 
unable to produce a measureable grip force, and were excluded from further grip 
strength analysis. There was no difference between FSH, LG and Be participants in 
terms of grip strength. 
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In terms of physical activity data in the dystrophy participants, BPAQ was not 
correlated with TAACSA or grip strength, whereas the PASIPD showed significant 
correlations with both TAACSA (r = 0.458, P < 0.01) and grip strength (r = 0.651, P < 
0.01). 
Bone QUS 
Across the upper and lower limb, there was no difference in T and Z scores between 
the CTRL and FSH and LG participants (Figure 3). The distal radius T and Z scores 
were lower in DMD than the CTRL participants, and were also lower in the DMD 
participants than FSH, LG and Be MD  (P<0.05, Figure 3A & B).   
There was a significant effect of age on MST T- and Z-scores (r = 0.360, and 0.398 
respectively, both P<0.01). ANCOVA showed a significant influence of Age as a co-
variable for MST Z-scores only (P<0.05), however group difference remained when 
age was controlled for (P < 0.001). 
When controlling for BPAQ, ANCOVA showed no significant difference between 
groups for any of the measures using bone QUS (Z & T-scores from MST and DR 
were all >0.05). When all dystrophy participants were pooled (n = 42) BPAQ was 
found to correlate significantly with bone QUS at both the DR and MST (Table 2). 
PASIPD did not correlate with any of the bone QUS data in the dystrophy 
participants. 
Due to the mixed ambulatory status of some of the dystrophy groups, bone QUS 
data is also presented as ambulatory compared to non-ambulatory participant 
groups. Significantly lower T- and Z- scores are observed in the DR of non-
ambulatory participants, compared to CTRL and Ambulatory participants with MD 
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(Figure 4, P<0.05). There was no difference in MST between ambulatory, non-
ambulatory and CTRL participants (Figure 4). 
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Discussion 
The main findings of the present study showed that bone health assessed using 
QUS was negatively affected in adult males with Becker’s and Duchenne muscle 
dystrophies. Furthermore, Z- and T scores of the MST and DR are influenced by 
physical activity (BPAQ) rather than ambulatory status; indeed when included as a 
covariable, BPAQ removed all group differences between the dystrophy groups. An 
additional novel finding from our adult males with muscular dystrophy, was that 
significant atrophy previously observed in some, but not all childhood dystrophies, is 
present in the TA of adult males with FSH, Be, LG and Duchenne muscular 
dystrophy.  
The present understanding of bone health in muscular dystrophies is primarily 
focused on DMD 12,21, and is understandably mainly from children; there are 
presently no studies to date that includes adult participants, and only a few with 
participants up to 18 yrs old 26. As would be expected given the severity of the 
impairments experienced by children with DMD, Z-scores are consistently lower than 
CTRLs and for the femur range from -1.6 to 3.9, depending on the ambulatory status 
of the participants 27. Consistent with previous data, the present study has observed 
significantly lower T- and Z- values from the DR and MST in adults with DMD 
compared to controls. Further to previous reports on DMD, the present data has also 
observed lower T- and Z-scores from the distal radius of adult males with Becker’s 
muscle dystrophy. In contrast to the more impaired Be MD and DMD participants, 
the present data showed FSH and LG dystrophies to be no different in bone QUS 
from CTRL. 
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The importance of childhood physical activity on bone health is well established in 
non-dystrophic populations 18. Consistent with previous 18, we have shown an 
influence of BPAQ on QUS T- and Z-scores. Specifically, the present study has 
shown that when physical activity is used as a covariant, there is no significant 
difference in DR and MST T- and Z-scores between CTRLs and the FSH, LG, Be 
and Duchenne muscular dystrophies; and that significant correlations exist between 
BPAQ and T- and Z-scores from the MST and DR in the pooled dystrophy 
populations.  
As previously mentioned, there is limited bone health data from adult muscular 
dystrophy populations; however, there are some studies that have reported higher 
bone fracture risks in adults with muscular dystrophy 28. The present data would be 
consistent with the increased likelihood of fracture incidence, such that our 
observations of lower muscle mass (discussed below), and lower bone health scores 
in the least active dystrophies (DMD and BeMD) may be influential to fracture risk. 
There are numerous variables that contribute to fracture risk in muscle dystrophy 13; 
the relationship between BPAQ and bone health data from the present study, would 
suggest that promoting bone loading through physical activity if, or whilst this is 
possible, may act to preserve bone health and reduce fracture risk as the dystrophic 
condition develops. Indeed, in the present data, we observed no association 
between current physical activity (PASIPD-7 day assessment of physical activity) 
and T- or Z- scores; whereas we see significant associations between lifespan 
physical activity (assessed through BPAQ), associated with T- and Z scores in the 
muscle dystrophies. This would certainly suggest the importance of some form of 
physical activity in adolescence on lower limb bone health in individuals with 
muscular dystrophy.  
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In addition to physical activity, muscle mass in proximity to the bone is known to be 
influential to BMD through the mechanostat 11. In the present study we observed no 
correlations between lower limb bone health scores and TAACSA. It is possible that 
the confounding influence of pseudohypertrophy in dystrophic populations and the 
unique patterns of loading and physical activity within this population, may interfere 
with the previously observed relationship between lower leg muscle mass and MST 
bone health 11. Similar to the TAACSA and MST T- and Z-scores, in the present study 
there was found to be no association between grip strength and DR T- and Z-scores 
in the Be, FSH and LG participants. Previously, grip strength and bone health have 
been associated 24, in the present dystrophic population groups the high coefficient 
of variation from the grip data (e.g. 90% in BeMD vs 19% in CTRL), and low absolute 
strength (approximately 54% weaker), may render grip strength redundant as a 
predictive measure of bone health in adult males with muscular dystrophy.  
Regardless of the high variability, the only previously published strength 
comparisons in dystrophic populations are from the knee extensors of 4-10 yr old 
boys with DMD 29. Our data shows that grip strength is lower by ~55% in adult males 
with FSH, LG and Be muscle dystrophies, compared to non-dystrophic CTRLs. Grip 
strength is employed for its ease of use and accessibility, particularly in clinical 
population groups 30, however its relevance to functional mobility/day-to-day physical 
independence, may be questioned above more meaningful measures of lower limb 
strength.  It is nonetheless notable that although there is no present data from grip 
strength in muscular dystrophy, it has previously been shown to be associated with 
mobility, lower limb strength and muscle mass in the elderly 31. Furthermore, our 
observed correlation between grip strength and current physical activity (assessed 
through PASIPD) in our participants with muscle dystrophy, suggest that, as with 
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muscle atrophy in ageing 31, grip strength may be a cost effective, and easily 
accessible measure of the progression of the dystrophic condition, and the general 
day-to-day functional capacity of the individual.   
Whilst we observed no association between MST T- and Z scores with TAACSA (see 
earlier in discussion), the TAACSA was found to be significantly smaller in the present 
adult males with muscular dystrophy. There is surprisingly limited data on 
appendicular muscle mass in adults with muscular dystrophy, such that the only 
extant, direct comparisons of muscle mass between adults with and without 
muscular dystrophy is from the GM in DMD 10. Similar to the GM, the present data 
shows significant atrophy in the TA in FSH, Be, LG and Duchenne muscular 
dystrophies. We have previously discussed the novelty of these findings in context of 
the apparent increase in muscle size or “pseudohypertrophy” observed in children 
with DMD 10. As with other atrophic conditions e.g. bed rest 32 and ageing 33, the 
present muscle size data from the MD participants, is positively associated with 
physical activity assessed through the PASIPD questionnaire. It would be too 
speculative to categorically state that increased physical activity is beneficial to 
muscle mass given the complex nature of each of the muscular dystrophies 
assessed within the present study.  However, given the possible contraindications, 
and equivocal findings of some physical training studies in MD 34, investigating 
standing time, and breaks in sedentary behaviour, may be more meaningful in those 
MD conditions in which weight bearing is possible. Indeed, breaks in sedentary 
behaviour and increased daily physical activity, have been suggested to be 
independent (though closely associated) modulators the health of otherwise 
sedentary individuals 35. 
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Despite the significant findings within the present study, it was somewhat surprising 
that, given the physical impairments experienced by these participants (the present 
participants scored in the lowest 45% of disabled participants tested for PASIPD19), 
only BeMD and DMD participants showed significantly lower bone health scores. 
There are two limitations to consider within the present study that may have 
influenced the extent to which bone health scores were impaired compared to 
controls; these are participant numbers and measurement technique.  Group sizes of 
between 9-14 participants are unlikely to be a factor in the present study, as post hoc 
power analysis revealed that all bone health scores were suitably powered (0.91-
0.94, for T and Z scores of DR and MST) with large effects sizes (0.57-0.59, 
G*Power, University of Kiel, Germany). It is likely however, that within the present 
study the sensitivity of discerning lower bone health would be enhanced with a more 
sensitive and direct measure of bone mineral density. As mentioned previously, QUS 
techniques show good agreement with pQCT measures of bone mineral density and 
measures of a bone’s material properties 14, and provide a valid method for comparing 
appendicular bone health between population groups 15. QUS cannot however, provide 
an absolute measure of bone mineral density, bone mineral content or bone geometry, 
and cannot distinguish cortical or trabecular bone, such as with DXA or PQCT36. 
Therefore, we would expect that the use of these latter techniques would confirm our 
observations from BeMD and DMD, but may identify further clinical observations in LG 
and FSH MD groups not identified using QUS. Further studies using PQCT and DXA 
would be essential in providing greater understanding of fracture risks in these 
participant groups28. 
Conclusion 
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The present study, has provided novel adult data comparisons of bone and muscle 
parameters in four types of muscular dystrophies against a non-dystrophic control 
group. It can be concluded that, muscle size, strength, and bone health is lower in 
adult males with muscle dystrophy compared to adult males without MD; and the 
extent of this is likely to be determined by previous physical activity.  
21 
 
References 
1. Emery AE. The muscular dystrophies. Lancet 2002;9307:687-695. 
2. Bushby K. The limb-girdle muscular dystrophies: diagnostic guidelines. Eur J 
Paediatr Neurol 1999;2:53-58. 
3. Mercuri E and Muntoni F. Muscular dystrophies. Lancet 2013;9869:845-860. 
4. Tawil R, Kissel JT, Heatwole C, et al. Evidence-based guideline summary: 
Evaluation, diagnosis, and management of facioscapulohumeral muscular 
dystrophy. Neurology 2015;4:357-364. 
5. Lue Y-J, Su C-Y, Yang R-C, et al. Development and validation of a muscular 
dystrophy-specific functional rating scale. Clin Rehab 2006;9:804-817. 
6. Dellorusso C, Crawford RW, Chamberlain JS, et al. Tibialis anterior muscles 
in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res 
Cell Motil 2001;5:467-75. 
7. Lovering RM, Shah SB, Pratt SJ, et al. Architecture of healthy and dystrophic 
muscles detected by optical coherence tomography. Muscle Nerve 
2013;4:588-90. 
8. Jones DA, Round JM, Edwards RH, et al. Size and composition of the calf 
and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and 
histochemical study. J Neurol Sci 1983;2:307-22. 
9. Lynch GS, Hinkle RT, Chamberlain JS, et al. Force and power output of fast 
and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 2001;Pt 
2:591-600. 
10. Morse CI, Smith J, Denny A, et al. Gastrocnemius medialis muscle 
architecture and physiological cross sectional area in adult males with 
Duchenne muscular dystrophy. J Musculoskelet Neuronal Interact 
2015;2:154-160. 
11. Rittweger J, Beller G, Ehrig J, et al. Bone-muscle strength indices for the 
human lower leg. Bone 2000;2:319-26. 
12. Bianchi ML, Mazzanti A, Galbiati E, et al. Bone mineral density and bone 
metabolism in Duchenne muscular dystrophy. Osteoporos Int 2003;9:761-7. 
13. Vestergaard P, Glerup H, Steffensen BF, et al. Fracture risk in patients with 
muscular dystrophy and spinal muscular atrophy. J Rehabil Med 2001;4:150-
5. 
14. Lee SC, Coan BS, and Bouxsein ML. Tibial ultrasound velocity measured in 
situ predicts the material properties of tibial cortical bone. Bone 1997;1:119-
25. 
15. Cook RB, Collins D, Tucker J, et al. The ability of peripheral quantitative 
ultrasound to identify patients with low bone mineral density in the hip or 
spine. Ultrasound Med Biol 2005;5:625-32. 
16. World Medical Association Declaration of Helsinki: ethical principles for 
medical research involving human subjects. JAMA 2013;20:2191-4. 
17. Reeves S, Varakamin C, and Henry C. The relationship between arm-span 
measurement and height with special reference to gender and ethnicity. Eur J 
Clin Nutr 1996;6:398-400. 
18. Weeks BK and Beck BR. The BPAQ: a bone-specific physical activity 
assessment instrument. Osteoporos Int 2008;11:1567-1577. 
19. Washburn RA, Zhu W, McAuley E, et al. The physical activity scale for 
individuals with physical disabilities: development and evaluation. Arch Phys 
Med Rehabil 2002;2:193-200. 
22 
 
20. van der Ploeg H, Streppel K, van der Beek A, et al. The physical activity scale 
for individuals with physical disabilities: test-retest reliability and comparison 
with two accelerometers. Arch Phys Med Rehabil 2005:41-56. 
21. Crabtree NJ, Roper H, McMurchie H, et al. Regional changes in bone area 
and bone mineral content in boys with Duchenne muscular dystrophy 
receiving corticosteroid therapy. J Pediatric 2010;3:450-455. e1. 
22. Fukunaga T, Roy R, Shellock F, et al. Physiological cross‐sectional area of 
human leg muscles based on magnetic resonance imaging. J Orthop Res 
1992;6:926-934. 
23. Reeves ND, Maganaris CN, and Narici MV. Ultrasonographic assessment of 
human skeletal muscle size. Eur J Appl Physiol 2004;1:116-8. 
24. Tsuji S, Tsunoda N, Yata H, et al. Relation between grip strength and radial 
bone mineral density in young athletes. Arch Phys Med Rehabil 1995;3:234-
238. 
25. Shechtman O, Gestewitz L, and Kimble C. Reliability and validity of the DynEx 
dynamometer. J Hand Ther 2005;3:339-47. 
26. Khatri IA, Chaudhry US, Seikaly MG, et al. Low bone mineral density in spinal 
muscular atrophy. J Clin Neur Dis 2008;1:11-17. 
27. Larson CM and Henderson RC. Bone mineral density and fractures in boys 
with Duchenne muscular dystrophy. J Pediatr Orthop 2000;1:71-4. 
28. Pouwels S, de Boer A, Leufkens H, et al. Risk of fracture in patients with 
muscular dystrophies. Osteoporos Int 2014;2:509-518. 
29. Marden FA, Connolly AM, Siegel MJ, et al. Compositional analysis of muscle 
in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 
2005;3:140-148. 
30. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European 
consensus on definition and diagnosis Report of the European Working Group 
on Sarcopenia in Older People. Age Ageing 2010:412-423. 
31. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in 
skeletal muscles and their effect on mobility: an operational diagnosis of 
sarcopenia. J Appl Physiol 2003;5:1851-1860. 
32. Rittweger J, Frost HM, Schiessl H, et al. Muscle atrophy and bone loss after 
90 days' bed rest and the effects of flywheel resistive exercise and 
pamidronate: results from the LTBR study. Bone 2005;6:1019-29. 
33. Baumgartner RN, Waters DL, Gallagher D, et al. Predictors of skeletal muscle 
mass in elderly men and women. Mech Ageing Dev 1999;2:123-136. 
34. van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al. Strength training and 
albuterol in facioscapulohumeral muscular dystrophy. Neurology 2004;4:702-
8. 
35. Tremblay MS, Colley RC, Saunders TJ, et al. Physiological and health 
implications of a sedentary lifestyle. Appl Physiol Nutr Metab 2010;6:725-740. 
36. Dowthwaite JN, Flowers PP, and Scerpella TA. Agreement between 
pQCT‐and DXA‐derived indices of bone geometry, density, and theoretical 
strength in females of varying age, maturity, and physical activity. J Bone 
Miner Res 2011;6:1349-1357. 
 
23 
 
 
Table 1: Participant demographics 
 CTRL LG FSH Be DMD 
n 14 9 11 11 11 
Age (yrs) 27.9 (10.8) 36.7 (12.9) 46.3 (10.3)C 38.2 (11.7) 25.4 (5.4) F 
Age range (yrs) 19-54 18-59 33-58 22-59 20-38 
Stature (m) 1.82 (0.09) 1.77 (0.10) 1.84 (0.08) 1.80 (0.08) 1.67 (0.10)C,F,B 
Mass (kg) 83.3 (11.5) 90.1 (20.5) 91.5 (20.6) 87.3 (15.6) 67.0 (17.5) F,B,L 
Grip strength 
(Kg) 
46.9 (9.1) 19.8 (11.2) C 23.6 (15.5) C 21.5 (19.2) C - 
PASIPD - 11.7 (7.8) 12.2 (11.8) 18.4 (21.0) 1.1 (0.6) F,B,L 
Ambulatory/non-
ambulatory (n) 
14/0 4/5 9/2 7/4 0/11 
 
CTRL = Control, LG = Limb Girdle, FSH = fascioscapulohumeral, Be = Becker’s, 
DMD = Duchenne. PASIPD = Physical activity score for individuals with physical 
disability. C denotes significant difference from CTRL, F denotes significant difference 
from FSH, B denotes significant difference from Be and L denotes significant 
difference from LG. Data are presented as Mean (SD). 
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Table 2: Bone QUS, muscle size and strength and physical activity in participants 
with muscular dystrophy. 
Variable  Activity 
Questionnaire  
Pearson’s Correlation P 
DR T-score BPAQ 0.407 <0.01 
DR Z-Score BPAQ 0.423 <0.01 
MST T-score BPAQ 0.390 <0.05 
MST Z-score BPAQ 0.387 <0.05 
TAACSA  PASIPD 0.458 <0.01 
Grip strength* PASIPD 0.651 <0.01 
 
Bone QUS recorded from the Distal radius (DR) and Mid-shaft tibia (MST) in the 
pooled dystrophy participants (n = 42). Tibialis Anterior Cross sectional area 
(TAACSA). *Duchenne muscular dystrophy participants omitted. 
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Figure Legends 
Figure 1: Bone Physical Activity Questionnaire (BPAQ) scores with and without 
muscular dystrophy. CTRL = Control, LG = Limb Girdle, FSH = 
fascioscapulohumeral, Be = Becker’s, DMD = Duchenne. C denotes significant 
difference from CTRL, F denotes significant difference from FSH, B denotes 
significant difference from Be and L denotes significant difference from LG (P<0.05). 
Data are presented as Mean (SD). 
Figure 2: Tibialis anterior Anatomical Cross sectional area (TAACSA) in adult males 
with and without muscular dystrophy. CTRL = Control, LG = Limb Girdle, FSH = 
fascioscapulohumeral, Be = Becker’s, DMD = Duchenne. C denotes significant 
difference from CTRL, B denotes significant difference from Be, P<0.05. Data are 
presented as Mean (SD). 
Figure 3: QUS bone health data in adult males with and without muscular dystrophy. 
Figure A = T score distal radius, B = Z score distal radius, C = T score Mid shaft 
tibia, D = Z score MST. CTRL = Control, LG = Limb Girdle, FSH = 
fascioscapulohumeral, Be = Becker’s, DMD = Duchenne. C denotes significant 
difference from CTRL, F denotes significant difference from FSH, B denotes 
significant difference from Be and L denotes significant difference from LG. Data are 
presented as Mean (SD).  
Figure 4: QUS bone health in adult males with and without (CTRL) muscular 
dystrophy who are ambulatory (A, n = 22) and Non-Ambulatory (NA, n = 20). Figure 
A=T score DR, B = Z score DR, C = T score MST, D = Z score MST. C denotes 
significant difference from CTRL P<0.05, A denotes significant difference from 
Ambulatory P<0.05. Data are presented as Mean (SD). 
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Figure 1 
 
Figure 1: Bone Physical Activity Questionnaire (BPAQ) scores with and without 
muscular dystrophy. CTRL = Control, LG = Limb Girdle, FSH = 
fascioscapulohumeral, Be = Becker’s, DMD = Duchenne. C denotes significant 
difference from CTRL, F denotes significant difference from FSH, B denotes 
significant difference from Be and L denotes significant difference from LG (P<0.05). 
Data are presented as Mean (SD). 
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Figure 2 
 
Figure 2: Tibialis anterior Anatomical Cross sectional area (TAACSA) in adult males 
with and without muscular dystrophy. CTRL = Control, LG = Limb Girdle, FSH = 
fascioscapulohumeral, Be = Becker’s, DMD = Duchenne. C denotes significant 
difference from CTRL, B denotes significant difference from Be, P<0.05. Data are 
presented as Mean (SD). 
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Figure 3 
 
Figure 3: QUS bone health data in adult males with and without muscular dystrophy. Figure A = T score distal radius (DR), B = Z 
score distal radius, C = T score Mid shaft tibia (MST), D = Z score mid shaft tibia. CTRL = Control, LG = Limb Girdle, FSH = 
fascioscapulohumeral, Be = Becker’s, DMD = Duchenne. C denotes significant difference from CTRL, F denotes significant 
difference from FSH, B denotes significant difference from Be and L denotes significant difference from LG. Data are presented as 
Mean (SD).  
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Figure 4 
 
 
Figure 4: QUS bone health data in adult males with and without (CTRL) muscular 
dystrophy who are ambulatory (A, n = 22) and Non-Ambulatory (NA, n = 20). Figure 
A=T score distal radius (DR), B = Z score DR, C = T score Mid shaft tibia (MST), D = 
Z score MST. C denotes significant difference from CTRL P<0.05, A denotes 
significant difference from Ambulatory P<0.05. Data are presented as Mean (SD). 
 
 
 
 
 
